BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alperin JM, Ortiz-Fernández L, Sawalha AH. Monogenic Lupus: A Developing Paradigm of Disease. Front Immunol 2018;9:2496. [PMID: 30459768 DOI: 10.3389/fimmu.2018.02496] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu E, Perl A. Pathogenesis and treatment of autoimmune rheumatic diseases. Curr Opin Rheumatol 2019;31:307-15. [PMID: 30920455 DOI: 10.1097/BOR.0000000000000594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 7.5] [Reference Citation Analysis]
2 Stok JE, Vega Quiroz ME, van der Veen AG. Self RNA Sensing by RIG-I–like Receptors in Viral Infection and Sterile Inflammation. J I 2020;205:883-91. [DOI: 10.4049/jimmunol.2000488] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Pisetsky DS. The basic and translational science year in review: Confucius in the era of Big Data. Semin Arthritis Rheum 2020;50:373-9. [PMID: 32238274 DOI: 10.1016/j.semarthrit.2020.02.010] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Moraes JC, Nunes FDD, Coeli-Lacchini FB, Miyazaki AHL, Flória-Santos M, Lacchini R. Nurse empowerment through Pharmacogenetics. Rev Lat Am Enfermagem 2020;28:e3265. [PMID: 32813781 DOI: 10.1590/1518-8345.3415.3265] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Caster DJ, Powell DW. Utilization of Biomarkers in Lupus Nephritis. Adv Chronic Kidney Dis 2019;26:351-9. [PMID: 31733719 DOI: 10.1053/j.ackd.2019.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
6 McCann LJ, Hedrich CM. Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets. Clin Immunol 2021;223:108647. [PMID: 33310069 DOI: 10.1016/j.clim.2020.108647] [Reference Citation Analysis]
7 Harley ITW, Sawalha AH. Systemic lupus erythematosus as a genetic disease. Clin Immunol 2022;:108953. [PMID: 35149194 DOI: 10.1016/j.clim.2022.108953] [Reference Citation Analysis]
8 Tocut M, Shoenfeld Y, Zandman-Goddard G. Systemic lupus erythematosus: an expert insight into emerging therapy agents in preclinical and early clinical development. Expert Opin Investig Drugs 2020;29:1151-62. [PMID: 32755494 DOI: 10.1080/13543784.2020.1807004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Dasdemir S, Yildiz M, Celebi D, Sahin S, Aliyeva N, Haslak F, Gunalp A, Adrovic A, Barut K, Artim Esen B, Kasapcopur O. Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel. Lupus 2022;:9612033221076733. [PMID: 35086391 DOI: 10.1177/09612033221076733] [Reference Citation Analysis]
10 Liu A, Zhou L, Zhu H, Li Y, Yang J, Qin S. Systemic Lupus Erythematosus and Hereditary Coproporphyria: Two Different Entities Diagnosed by WES in the Same Patient. BioMed Research International 2022;2022:1-7. [DOI: 10.1155/2022/9096999] [Reference Citation Analysis]
11 Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol 2020;146:925-37. [PMID: 33160483 DOI: 10.1016/j.jaci.2020.08.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
12 Jiang SH, Stanley M, Vinuesa CG. Rare genetic variants in systemic autoimmunity. Immunol Cell Biol 2020;98:490-9. [PMID: 32315078 DOI: 10.1111/imcb.12339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Huijser E, Versnel MA. Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's Syndrome. J Clin Med 2021;10:532. [PMID: 33540529 DOI: 10.3390/jcm10030532] [Reference Citation Analysis]
14 Qiu CC, Caricchio R, Gallucci S. Triggers of Autoimmunity: The Role of Bacterial Infections in the Extracellular Exposure of Lupus Nuclear Autoantigens. Front Immunol 2019;10:2608. [PMID: 31781110 DOI: 10.3389/fimmu.2019.02608] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
15 Massias JS, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. Lupus 2021;30:597-607. [PMID: 33413005 DOI: 10.1177/0961203320984251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Günther C. Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus. Front Immunol 2019;10:1636. [PMID: 31379837 DOI: 10.3389/fimmu.2019.01636] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
17 Owen KA, Grammer AC, Lipsky PE. Deconvoluting the heterogeneity of SLE: The contribution of ancestry. J Allergy Clin Immunol 2021:S0091-6749(21)01762-0. [PMID: 34857396 DOI: 10.1016/j.jaci.2021.11.005] [Reference Citation Analysis]
18 Oparina N, Martínez-bueno M, Alarcón-riquelme ME. An update on the genetics of systemic lupus erythematosus. Current Opinion in Rheumatology 2019;31:659-68. [DOI: 10.1097/bor.0000000000000654] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
19 Al-Mayouf SM, Akbar L, Abdwani R, Ginesi G, Volpi S, Gattorno M, Bakry R, AlHashim S, Alsaleem A. Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus. Clin Rheumatol 2022. [PMID: 35590114 DOI: 10.1007/s10067-022-06209-9] [Reference Citation Analysis]
20 Genest DS, Bonnefoy A, Khalili M, Merlen C, Genest G, Lapeyraque A, Patey N, Smail N, Royal V, Troyanov S. Comparison of Complement Pathway Activation in Autoimmune Glomerulonephritis. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.002] [Reference Citation Analysis]
21 Demirkaya E, Sahin S, Romano M, Zhou Q, Aksentijevich I. New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and Beyond. J Clin Med 2020;9:E712. [PMID: 32151092 DOI: 10.3390/jcm9030712] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
22 Liphaus BL, Caramalho I, Rangel-Santos A, Silva CA, Demengeot J, Carneiro-Sampaio MMS. LRBA deficiency: a new genetic cause of monogenic lupus. Ann Rheum Dis 2020;79:427-8. [PMID: 31852671 DOI: 10.1136/annrheumdis-2019-216410] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
23 Han S, Zhuang H, Lee PY, Li M, Yang L, Nigrovic PA, Reeves WH. NF-E2-Related Factor 2 Regulates Interferon Receptor Expression and Alters Macrophage Polarization in Lupus. Arthritis Rheumatol 2020;72:1707-20. [PMID: 32500632 DOI: 10.1002/art.41383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Catalina MD, Owen KA, Labonte AC, Grammer AC, Lipsky PE. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus. J Autoimmun 2020;110:102359. [PMID: 31806421 DOI: 10.1016/j.jaut.2019.102359] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
25 Kumar V. A STING to inflammation and autoimmunity. J Leukoc Biol 2019;106:171-85. [PMID: 30990921 DOI: 10.1002/JLB.4MIR1018-397RR] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 9.3] [Reference Citation Analysis]
26 Sugrue JA, Bourke NM, O'Farrelly C. Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature. Front Immunol 2021;12:757249. [PMID: 34917078 DOI: 10.3389/fimmu.2021.757249] [Reference Citation Analysis]
27 d'Angelo DM, Di Filippo P, Breda L, Chiarelli F. Type I Interferonopathies in Children: An Overview. Front Pediatr 2021;9:631329. [PMID: 33869112 DOI: 10.3389/fped.2021.631329] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Kisla Ekinci RM, Balci S, Ozcan D, Atmis B, Bisgin A. Monogenic lupus due to DNASE1L3 deficiency in a pediatric patient with urticarial rash, hypocomplementemia, pulmonary hemorrhage, and immune-complex glomerulonephritis. Eur J Med Genet 2021;64:104262. [PMID: 34161863 DOI: 10.1016/j.ejmg.2021.104262] [Reference Citation Analysis]
29 David C, Frémond ML. [When to consider type I interferonopathy in adulthood?]. Rev Med Interne 2022:S0248-8663(21)01114-0. [PMID: 35177256 DOI: 10.1016/j.revmed.2021.11.003] [Reference Citation Analysis]
30 Shukla A, Gaur P. Hereditary C1 inhibitor deficiency associated with systemic lupus erythematosus. Lupus 2020;29:1456-60. [PMID: 32659156 DOI: 10.1177/0961203320935980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Akbar L, Alsagheir R, Al-Mayouf SM. Efficacy of a sequential treatment by belimumab in monogenic systemic lupus erythematosus. Eur J Rheumatol 2020. [PMID: 32910770 DOI: 10.5152/eurjrheum.2020.20087] [Reference Citation Analysis]
32 Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus. Paediatr Drugs 2021;23:331-47. [PMID: 34244988 DOI: 10.1007/s40272-021-00457-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Brown GJ, Cañete PF, Wang H, Medhavy A, Bones J, Roco JA, He Y, Qin Y, Cappello J, Ellyard JI, Bassett K, Shen Q, Burgio G, Zhang Y, Turnbull C, Meng X, Wu P, Cho E, Miosge LA, Andrews TD, Field MA, Tvorogov D, Lopez AF, Babon JJ, López CA, Gónzalez-Murillo Á, Garulo DC, Pascual V, Levy T, Mallack EJ, Calame DG, Lotze T, Lupski JR, Ding H, Ullah TR, Walters GD, Koina ME, Cook MC, Shen N, de Lucas Collantes C, Corry B, Gantier MP, Athanasopoulos V, Vinuesa CG. TLR7 gain-of-function genetic variation causes human lupus. Nature 2022;605:349-56. [PMID: 35477763 DOI: 10.1038/s41586-022-04642-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jodele S, Medvedovic M, Luebbering N, Chen J, Dandoy CE, Laskin BL, Davies SM. Interferon-complement loop in transplant-associated thrombotic microangiopathy. Blood Adv 2020;4:1166-77. [PMID: 32208488 DOI: 10.1182/bloodadvances.2020001515] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
35 Ham YJ, Nicklason E, Wightman T, Akom S, Sandhu K, Harraka P, Colville D, Catran A, Barit D, Langsford D, Pianta T, Foote A, Buchanan R, Mack H, Savige J. Retinal drusen are more common and larger in SLE with renal impairment. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1063] [Reference Citation Analysis]
36 Di Donato G, d'Angelo DM, Breda L, Chiarelli F. Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives. Int J Mol Sci 2021;22:6360. [PMID: 34198614 DOI: 10.3390/ijms22126360] [Reference Citation Analysis]
37 Papa R, Volpi S, Gattorno M. Monogenetic causes of chilblains, panniculitis and vasculopathy: the Type I interferonopathies. G Ital Dermatol Venereol 2020;155:590-8. [PMID: 32618445 DOI: 10.23736/S0392-0488.20.06709-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Paç Kisaarslan A, Witzel M, Unal E, Rohlfs M, Akyildiz B, Dogan ME, Poyrazoglu H, Klein C, Patiroglu T. Refractory and Fatal Presentation of Severe Autoimmune Hemolytic Anemia in a Child With the DNASE1L3 Mutation Complicated With an Additional DOCK8 Variant. J Pediatr Hematol Oncol 2021;43:e452-6. [PMID: 32205782 DOI: 10.1097/MPH.0000000000001780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
39 Massias JS, Smith EMD, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus 2020;29:474-81. [PMID: 32233733 DOI: 10.1177/0961203320909156] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
40 Sait H, Gangadharan H, Gupta A, Aggarwal A, Jain M, Phadke SR. Monogenic Lupus with IgA Nephropathy Caused by Spondyloenchondrodysplasia with Immune Dysregulation. Indian J Pediatr 2021;88:819-23. [PMID: 33712926 DOI: 10.1007/s12098-020-03636-x] [Reference Citation Analysis]
41 Gloude NJ, Dandoy CE, Davies SM, Myers KC, Jordan MB, Marsh RA, Kumar A, Bleesing J, Teusink-Cross A, Jodele S. Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy. J Clin Immunol 2020;40:699-707. [PMID: 32447592 DOI: 10.1007/s10875-020-00789-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
42 Reid S. From Prehistory to Precision Medicine: Are Genetic Risk Scores Our Next Step? J Rheumatol 2021;48:799-801. [PMID: 33722950 DOI: 10.3899/jrheum.201256] [Reference Citation Analysis]
43 Kim HY, Jo HY, Kim SH. Clinical and Laboratory Characteristics of Kikuchi-Fujimoto Disease According to Age. Front Pediatr 2021;9:745506. [PMID: 34796153 DOI: 10.3389/fped.2021.745506] [Reference Citation Analysis]